Betaclav-625

Amoxycillin & Potassium Clavulanate Tablets I.P. 625 mg

“ Broad-Spectrum Power Against Bacterial Infections ”

Product Overview

BETACLAV-625 Tablets are a broad-spectrum antibiotic combination formulated to effectively treat a wide range of bacterial infections. The synergistic combination of Amoxycillin and Potassium Clavulanate provides enhanced antibacterial activity by eliminating susceptible bacteria while overcoming beta-lactamase-mediated resistance.

🔬 Mechanism of Action (Ingredients)

✦ Amoxycillin (500 mg)

Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs).
Disrupts cell wall peptidoglycan cross-linking, causing bacterial lysis and cell death.
Active against a wide array of Gram-positive and Gram-negative pathogens.

✦ Potassium Clavulanate (125 mg)

Acts as a beta-lactamase inhibitor, protecting Amoxycillin from enzymatic degradation.
Restores Amoxycillin efficacy against beta-lactamase-producing resistant bacteria.
Enhances overall success in mixed and deep-tissue bacterial infections.

🎯 Approved Clinical Indications

• Upper & Lower Respiratory Tract Infections

• Ear, Nose & Throat (ENT) Infections

• Acute Sinusitis

• Tonsillitis & Pharyngitis

• Urinary Tract Infections (UTIs)

• Skin & Soft Tissue Infections

📦 Product Packaging

📊 Clinical Efficacy & Study Data

Comparative clinical charts derived from pharmacokinetics data showing efficacy parameters.